↓ Skip to main content

PLOS

Prospective Study of the Evolution of Blood Lymphoid Immune Parameters during Dacarbazine Chemotherapy in Metastatic and Locally Advanced Melanoma Patients

Overview of attention for article published in PLOS ONE, August 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
15 Mendeley
Title
Prospective Study of the Evolution of Blood Lymphoid Immune Parameters during Dacarbazine Chemotherapy in Metastatic and Locally Advanced Melanoma Patients
Published in
PLOS ONE, August 2014
DOI 10.1371/journal.pone.0105907
Pubmed ID
Authors

Grégoire Mignot, Alice Hervieu, Pierre Vabres, Sophie Dalac, Geraldine Jeudy, Blandine Bel, Lionel Apetoh, François Ghiringhelli

Abstract

The importance of immune responses in the control of melanoma growth is well known. However, the implication of these antitumor immune responses in the efficacy of dacarbazine, a cytotoxic drug classically used in the treatment of melanoma, remains poorly understood in humans.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 20%
Other 2 13%
Student > Master 2 13%
Professor 1 7%
Student > Bachelor 1 7%
Other 1 7%
Unknown 5 33%
Readers by discipline Count As %
Agricultural and Biological Sciences 3 20%
Medicine and Dentistry 3 20%
Biochemistry, Genetics and Molecular Biology 2 13%
Engineering 2 13%
Unknown 5 33%